New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - diphtheria antitoxin 10000 [iu] - solution for injection - 10000 iu - active: diphtheria antitoxin 10000 [iu] excipient: hydrochloric acid phenol sodium chloride sodium hydroxide water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmabroker sales ltd - diphtheria antitoxin 2000 iu/ml - solution for injection - 2000 iu/ml - active: diphtheria antitoxin 2000 iu/ml excipient: phenol

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmabroker sales ltd - diphtheria antitoxin 4000 iu/ml - solution for injection - 4000 iu/ml - active: diphtheria antitoxin 4000 iu/ml excipient: phenol

Canada - English - Health Canada

connaught laboratories ltd. - diphtheria antitoxin - liquid - 1000unit - diphtheria antitoxin 1000unit - serums

Canada - English - Health Canada

aventis pasteur limited - diphtheria antitoxin - liquid - 20000unit - diphtheria antitoxin 20000unit - serums

United States - English - NLM (National Library of Medicine)

sanofi pasteur inc. - corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (unii: irh51qn26h) (corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) - unii:irh51qn26h), clostridium tetani toxoid antigen (formaldehyde inactivated) (unii: k3w1n8yp13) (clostridium tetani toxoid antigen (formaldehyde inactivated) - unii:k3w1n8yp13) - corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) 25 [lf] in 0.5 ml - diphtheria and tetanus toxoids adsorbed is a vaccine indicated for active immunization against diphtheria and tetanus. diphtheria and tetanus toxoids adsorbed is approved for use in children from 6 weeks through 6 years of age (prior to 7th birthday). diphtheria and tetanus toxoids and acellular pertussis vaccine (dtap) or a dtap-containing vaccine is recommended for immunization of infants and children 6 weeks through 6 years of age. diphtheria and tetanus toxoids adsorbed should be used in instances where the pertussis vaccine component is contraindicated. diphtheria and tetanus toxoids adsorbed is not to be used for treatment of diphtheria or tetanus infection. a severe allergic reaction (e.g., anaphylaxis) after a previous dose of diphtheria and tetanus toxoids adsorbed or any other diphtheria toxoid or tetanus toxoid-containing vaccine, or any other component of this vaccine is a contraindication to administration of diphtheria and tetanus toxoids adsorbed. [see description (11). ] diphtheria and tetanu

Kenya - English - Pharmacy and Poisons Board

biological e. ltd 18 / 1 & 3, azamabad, hyderabad, telangana - - diphtheria and tetanus vaccine (adsorbed, reduced… - suspension for injection - diphtheria toxoid 2 lf (>/ 2 iu), tetanus toxoid… - tetanus toxoid combinations with diphtheria toxoid

Ireland - English - HPRA (Health Products Regulatory Authority)

wellcome (ireland) limited - diphtheria antitoxin -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - diphtheria toxoid, quantity: 2 iu; pertussis filamentous haemagglutinin, quantity: 5 microgram; pertussis toxoid, quantity: 2.5 microgram; pertussis fimbriae 2 + 3, quantity: 5 microgram; pertactin, quantity: 3 microgram; tetanus toxoid, quantity: 20 iu - injection, suspension - excipient ingredients: glutaral; formaldehyde; phenoxyethanol; water for injections; aluminium phosphate - adacel is indicated for active immunisation against tetanus, diphtheria and pertussis in persons aged 10 years and over as a booster following primary immunisation. adacel may be administered during pregnancy for prevention of pertussis in young infants via transplacental antibody transfer from the pregnant woman to the fetus.

Ireland - English - HPRA (Health Products Regulatory Authority)

wellcome (ireland) limited - diphtheria antitoxin -